Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
Titel:
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
Auteur:
Hurvitz, Sara A Bardia, Aditya Quiroga, Vanesa Park, Yeon Hee Blancas, Isabel Alonso-Romero, José Luis Vasiliev, Aleksandr Adamchuk, Hryhoriy Salgado, Marcelo Yardley, Denise A Berzoy, Oleksandr Zamora-Auñón, Pilar Chan, David Spera, Gonzalo Xue, Cloris Ferreira, Erika Badovinac Crnjevic, Tanja Pérez-Moreno, Pablo Diego López-Valverde, Vanesa Steinseifer, Jutta Fernando, Tharu M Moore, Heather M Fasching, Peter A
Verschenen in:
Lancet oncology
Paginering:
Jaargang 24 () nr. 9 pagina's 1029-1041
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license